Surfactant adjunctive therapy for Pneumocystis carinii pneumonitis in an infant with acute lymphoblastic leukaemia
- PMID: 7790617
- PMCID: PMC7094930
- DOI: 10.1007/BF01701485
Surfactant adjunctive therapy for Pneumocystis carinii pneumonitis in an infant with acute lymphoblastic leukaemia
Abstract
We report successful treatment of adult respiratory distress syndrome (ARDS) with artificial surfactant (40mg/kg, Colfosceril Palmitate, ‘Exosurf’, Wellcome) in an infant with severePneumocystis carinii pneumonitis.
Comment in
-
Use of natural surfactant in an HIV-infected infant with Pneumocystis carinii pneumonia.Intensive Care Med. 1996 Jun;22(6):611-2. doi: 10.1007/BF01708109. Intensive Care Med. 1996. PMID: 8814483 No abstract available.
References
-
- Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988;138:720–723. - PubMed
-
- Bozzette SA, Sattler FR, Chui J, et al. A controlled trial of early adjunctive treatment with corticosteroids forPneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med. 1990;323:1451–1457. - PubMed
-
- Bernard GR, Luce JM, Sprung CL, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med. 1987;317:1565–1570. - PubMed
-
- Tamburro RF, Bugnitz MC, Stidham GL. Alveolar-arterial oxygen gradient as a predictor of outcome in patients with non-neonatal pediatric respiratory failure. J Pediatr. 1991;119:935–938. - PubMed
-
- Mason GR, Hashimoto CH, Dickman PS, Foutty LF, Cobb CJ. Prognostic implications of bronchoalveolar lavage neutrophilia in patients withPneumocystis carinii pneumonia and AIDS. Am Rev Respir Dis. 1989;139:1336–1342. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources